Endovenous Ablation

Endovenous ablation, a groundbreaking treatment for large varicose veins, was pioneered at Cornell University in New York. This innovative procedure offers a minimally invasive alternative to traditional surgery, transforming the way varicose veins are treated. Endovenous Laser Treatment (EVLT), also known as Endovenous Laser Ablation (ELA), is the specific technique developed at Cornell. It involves the use of laser energy to close off problematic veins. The procedure can be performed in less than an hour, making it a quick and convenient option for patients. One of the significant advantages of this technique is that it virtually eliminates the need for surgery in patients with varicose veins. This implies fewer risks and complications associated with invasive surgical procedures, such as infections or long recovery periods. The success of this treatment approach has been demonstrated in various studies. For instance, a long-term study published by doctors at NewYork-Presbyterian Hospital showed endovenous treatment to have better results and far fewer risks compared to traditional surgery. The pioneering work carried out at Cornell University has had a profound impact on the field of vein treatment, offering patients an effective, less invasive, and safer alternative to traditional surgical interventions.

Venous insufficiency is generally recognized as a medical issue, and consequently, the examination and treatment of the fundamental problematic veins are typically covered by Medicare and most insurance policies. Patients are often mandated to undergo an initial period of conservative treatment using compression stockings. Depending on their reaction to this initial treatment, they may be considered for additional therapeutic medical treatments.